Kalaris Therapeutics KLRS
NASDAQ KLRS
$1.90 +0.03 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Kalaris Therapeutics (KLRS) Other Non-Current Liabilities (2024 - 2026)

Updated

Kalaris Therapeutics' Other Non-Current Liabilities came in at $32.08 million for Q2 2026, unchanged from $32.08 million a year earlier and unchanged from the prior quarter.

Analysis

Kalaris Therapeutics (KLRS) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends

Going back to Q4 2024, Kalaris Therapeutics' Other Non-Current Liabilities data covers 7 quarters.

  • Going back by year, Other Non-Current Liabilities was $32.08 million in FY2024.
  • Business Quant data shows KLRS's Other Non-Current Liabilities at $32.08 million (Q1 2026), $32.08 million (Q4 2025) and $32.08 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Kalaris Therapeutics 44.52 Mn -38.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 32.08 Mn
Jun 30, 2026 32.08 Mn
Mar 31, 2026 32.08 Mn
Dec 31, 2025 32.08 Mn
Sep 30, 2025 32.08 Mn
Jun 30, 2025 32.08 Mn
Mar 31, 2025 32.08 Mn
Dec 31, 2024 32.08 Mn
Sep 30, 2024 32.04 Mn
API Access

Kalaris Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KLRS&period=max&api_key=YOUR_API_KEY